522,109 Shares in Astrana Health, Inc. (NASDAQ:ASTH) Bought by Loomis Sayles & Co. L P

Loomis Sayles & Co. L P purchased a new stake in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 522,109 shares of the company's stock, valued at approximately $30,251,000. Loomis Sayles & Co. L P owned 1.06% of Astrana Health at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Central Pacific Bank Trust Division bought a new stake in shares of Astrana Health in the third quarter valued at about $160,000. SG Americas Securities LLC bought a new stake in Astrana Health in the 3rd quarter valued at about $680,000. Granite Bay Wealth Management LLC acquired a new position in shares of Astrana Health during the 3rd quarter worth approximately $290,000. Handelsbanken Fonder AB acquired a new stake in shares of Astrana Health in the third quarter valued at approximately $492,000. Finally, GAMMA Investing LLC bought a new stake in shares of Astrana Health in the third quarter valued at approximately $34,000. 52.77% of the stock is owned by institutional investors and hedge funds.

Astrana Health Price Performance

Astrana Health stock traded up $0.06 during mid-day trading on Tuesday, reaching $42.46. The company had a trading volume of 308,672 shares, compared to its average volume of 210,457. The business has a fifty day simple moving average of $53.91 and a 200 day simple moving average of $47.96. The company has a market cap of $2.39 billion, a P/E ratio of 32.66, a P/E/G ratio of 1.95 and a beta of 1.24. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. Astrana Health, Inc. has a fifty-two week low of $32.32 and a fifty-two week high of $63.20.

Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its quarterly earnings data on Thursday, November 7th. The company reported $0.33 earnings per share for the quarter, hitting analysts' consensus estimates of $0.33. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The business had revenue of $478.71 million for the quarter, compared to analyst estimates of $462.01 million. During the same quarter in the previous year, the company posted $0.47 EPS. On average, equities research analysts predict that Astrana Health, Inc. will post 1.17 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. Robert W. Baird lifted their price objective on Astrana Health from $67.00 to $86.00 and gave the company an "outperform" rating in a report on Wednesday, November 13th. TD Cowen assumed coverage on shares of Astrana Health in a research report on Monday, October 14th. They set a "buy" rating and a $66.00 price objective for the company. Truist Financial boosted their target price on shares of Astrana Health from $50.00 to $59.00 and gave the company a "buy" rating in a research report on Friday, August 9th. Stifel Nicolaus increased their price target on shares of Astrana Health from $48.00 to $60.00 and gave the stock a "buy" rating in a research report on Thursday, August 1st. Finally, BTIG Research boosted their price objective on shares of Astrana Health from $60.00 to $70.00 and gave the company a "buy" rating in a research report on Thursday, October 3rd. One analyst has rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company has an average rating of "Buy" and a consensus target price of $65.17.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.